The UW Drug Interaction Database team will be attending the 12th International ISSX Meeting in Portland next week. In addition to our booth #316, we hope to meet you at one of our posters:
- “Main mechanisms of PK DDIs triggering label recommendations for drugs approved by FDA in 2018”; presented by Dr. Jingjing Yu on July 29 at 11am
- “Variability of OATP1B1/1B3 in vitro inhibition constants and the resulting impact on clinical evaluation”; presented by Dr. Savannah McFeely on July 31st at 12:30pm.